BioSpace News Archive

Tarveda Therapeutics, Inc. today announced that Drew Fromkin, President and Chief Executive Officer, will present at the 2018 BIO International Convention.

The California State University Institute for Palliative Care has announced the keynote speakers headlining this year’s National Symposium for Academic Palliative Care Education and Research.

Points Group and PatientTrak a leader in patient satisfaction solutions, have announced a partnership between the two companies.

Genprex, Inc. based upon a novel proprietary technology platform, announced today that its management team will ring the Nasdaq stock market closing bell on Thursday, May 31, 2018.

PharmaMar (MCE: PHM) has announced today that the Independent Data Monitoring Committee (IDMC) has notified the Company of its recommendation that the Phase III (ATLANTIS) trial currently under way with Zepsyre(R) (lurbinectedin, PM1183) in combination with doxorubicin in small-cell lung cancer patients should continue without any changes.

The research team behind an emerging immunotherapy for cancer will present interim findings from an ongoing clinical study in patients with brain cancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Senior Executive with Global Pharmaceutical Development and Manufacturing Experience

May is Hepatitis Awareness Month, representing an important time to highlight this hidden epidemic by raising awareness of viral hepatitis and its impact in the United States.

Strategic Consulting, Inc. announced that the 5th Edition of their industry-standard Industrial Microbiology Market Report will be published and released in June 2018.

Genetics Leader Kashi Clinical Labs unveils ‘Defy Your DNA Program,’ a unique genetic health panel providing fast and accurate information on a range of SNPs related to optimizing health